EuroCCP, EMCF Complete Merger Transaction

amsterdam-2
EuroCCP NV will be headquartered in Amsterdam, Netherlands.

EMCF will be known as European Central Counterparty NV from January 6. The two firms announced their intentions to combine in March 2013, and received unconditional approval from the UK Office of Fair Trading in October. The Dutch Central Bank also gave recent approval to the addition of BATS Chi-X Europe and the Depository Trust and Clearing Corporation as new shareholders in EMCF, removing the final barrier to the transaction. Equal shareholders in the new company will include the two companies just mentioned, as well as ABN Amro Clearing Bank and Nasdaq OMX.

Diana Chan, CEO of EuroCCP, will remain at the head of the new entity. EMCF CEO Jan Booij will become COO.

"Bringing together the best of EMCF and EuroCCP is transformational for the industry and, as we lead the way in risk management, technology, settlement and client service, our customers will be the ultimate beneficiaries," says Booij. "Our goal is to complete the migration of customers to the new company by March 31, 2014, and we are on track to meet this objective."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

A tech revolution in an old-school industry: FX

FX is in a state of transition, as asset managers and financial firms explore modernizing their operating processes. But manual processes persist. MillTechFX’s Eric Huttman makes the case for doubling down on new technology and embracing automation to increase operational efficiency in FX.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here